These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 37935721)
1. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer. Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721 [TBL] [Abstract][Full Text] [Related]
2. Prediction of prognosis and immunotherapy response in breast cancer based on neutrophil extracellular traps-related classification. Zhao J; Xie X Front Mol Biosci; 2023; 10():1165776. PubMed ID: 37304069 [TBL] [Abstract][Full Text] [Related]
3. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps. Zuo Y; Leng G; Leng P Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472 [No Abstract] [Full Text] [Related]
4. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [No Abstract] [Full Text] [Related]
5. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma. Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP Front Oncol; 2022; 12():1094248. PubMed ID: 36620592 [TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps. Tu Y; Mao Z Cancer Invest; 2023 Apr; 41(4):354-368. PubMed ID: 36762827 [TBL] [Abstract][Full Text] [Related]
7. Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinoma. Xu Q; Ying H; Xie C; Lin R; Huang Y; Zhu R; Liao Y; Zeng Y; Yu F J Gene Med; 2023 Nov; 25(11):e3551. PubMed ID: 37401256 [TBL] [Abstract][Full Text] [Related]
8. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [TBL] [Abstract][Full Text] [Related]
9. Machine learning framework develops neutrophil extracellular traps model for clinical outcome and immunotherapy response in lung adenocarcinoma. Han AX; Long BY; Li CY; Huang DD; Xiong EQ; Li FJ; Wu GL; Liu Q; Yang GB; Hu HY Apoptosis; 2024 Aug; 29(7-8):1090-1108. PubMed ID: 38519636 [TBL] [Abstract][Full Text] [Related]
10. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme. Sun G; Liu W Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685 [TBL] [Abstract][Full Text] [Related]
11. A signature for pan-cancer prognosis based on neutrophil extracellular traps. Zhang Y; Guo L; Dai Q; Shang B; Xiao T; Di X; Zhang K; Feng L; Shou J; Wang Y J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688556 [TBL] [Abstract][Full Text] [Related]
12. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma. Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J Front Immunol; 2022; 13():881359. PubMed ID: 35911752 [TBL] [Abstract][Full Text] [Related]
13. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma. Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X Front Oncol; 2023; 13():1152681. PubMed ID: 37333810 [TBL] [Abstract][Full Text] [Related]
14. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
15. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
16. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma. Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H Front Immunol; 2021; 12():769685. PubMed ID: 35003085 [TBL] [Abstract][Full Text] [Related]
17. Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma. Wang Y; Lin MG; Meng L; Chen ZM; Wei ZJ; Ying SC; Xu A Front Oncol; 2022; 12():941156. PubMed ID: 36505813 [TBL] [Abstract][Full Text] [Related]
18. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma. Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338 [TBL] [Abstract][Full Text] [Related]
19. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer. Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy. Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q Front Immunol; 2023; 14():1301452. PubMed ID: 38045683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]